PharmaShots | Incisive News in 3 Shots

Subscribe Now

GenFleet Therapeutics

The NMPA Accepts GenFleet Therapeutics’ NDA for GFH925 and Grants Priority Review for Lung Cancer

The NMPA Accepts GenFleet Therapeutics’ NDA for GFH925 and Grants Priority Review for Lung Cancer

November 27, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us